CDER-Tobacco Center Joint Meeting Could Signal Talks On NRT Indications
This article was originally published in The Tan Sheet
Executive Summary
FDA's work to implement its tobacco control authorities includes planning a joint meeting of its drug and tobacco centers to address issues such as the extended use of nicotine replacement therapy
You may also be interested in...
Advisory Committee On NRT Indications Appears Likely Following Workshop
Speakers at a workshop on nicotine-replacement therapy point abroad for guidance on expanding indications for smoking-cessation products as an FDA official says the agency likely will put the question before an advisory committee.
Advisory Committee On NRT Indications Appears Likely Following Workshop
Speakers at a workshop on nicotine-replacement therapy point abroad for guidance on expanding indications for smoking-cessation products as an FDA official says the agency likely will put the question before an advisory committee.
Advisory Committee On NRT Indications Appears Likely Following Workshop
Speakers at a workshop on nicotine-replacement therapy point abroad for guidance on expanding indications for smoking-cessation products as an FDA official says the agency likely will put the question before an advisory committee.